<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>
SAN DIEGO, July 7, 2021 /PRNewswire/ — Johnson Fistel, LLP is investigating potential claims on behalf of ChemoCentryx Inc. (“ChemoCentryx” or the “Company”) (NASDAQ: CCXI) against certain of its current and former officers and directors. Recently a class action lawsuit was filed in federal court against the Company on behalf of purchasers of the securities of ChemoCentryx from November 26, 2019 and May 6, 2021 (the “Class Period”).
...read full article on PRNewsWire
